FDA Defends European Pilot Program, Seeks More Applicants
The Food and Drug Administration on Wednesday urged applicants working on complex generic drugs to seek out joint meetings with U.S. and European regulators under a 2021 pilot program designed to...To view the full article, register now.
Already a subscriber? Click here to view full article